drugset / Trial / NCT02755259

Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension

NCT02755259

Phase 2/3 Completed 33 enrolled University of Zurich
RandomizedCrossoverDouble-blindTreatment

Summary

To study the acute effect of acetazolamide (AZA) on pulmonary hemodynamics in patients with pulmonary hypertension (PH) undergoing clinically indicated right heart catheterisation (RHC).

Timeline

Start
2017-01-01
Primary completion
2019-04-05
Completion
2019-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Intravenous